[Health Technology Assessment: a value-based tool for the evaluation of healthcare technologies. Reassessment of the cell-culture-derived quadrivalent influenza vaccine: Flucelvax Tetra® 2.0].
Calabrò GE, Boccalini S, Bechini A, Panatto D, Domnich A, Lai PL, Amicizia D, Rizzo C, Pugliese A, DI Pietro ML, Zanella B, Parente F, Trombetta CS, Saraceno G, Sottile S, Abreha FM, Giacchetta I, Properzi S, Santolini G, D'Ambrosio F, Maida A, Scardigno A, LA Gatta E, Petrella L, Bonanni P, DE Waure C.
Calabrò GE, et al. Among authors: scardigno a.
J Prev Med Hyg. 2023 Mar 2;63(4 Suppl 1):E1-E140. doi: 10.15167/2421-4248/jpmh2022.63.4s1. eCollection 2022 Dec.
J Prev Med Hyg. 2023.
PMID: 37034835
Free PMC article.
Italian.
No abstract available.